A clinical study to see the effect of ayurvedic drug in the management of Shushkakshipaka w.s.r. to dry eye syndrome

A randomized clinical Study to evaluate Mahoushadha Anjana and Shamana Snehapana in the management of Shushkakshipaka w.s.r.to dry eye syndrome

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021470

Enrollment

Registered

2019-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H05- Disorders of eyelid, lacrimal system and orbit

Interventions

Intervention1: shunt Powder with Erandbrashtaharitaki mahoushadha Anjana with Triphala Ghritta: Shunti Power 1.5 gm twice a day with luke warm water for 5 days and Erandbrashtaharitaki 4 gm once at ni

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with signs and symptoms of shushkakshipaka described as per Ayurveda and mordern parlance

Exclusion criteria

Exclusion criteria: 1.Severe cases of dry eye with complication like perforated corneal ulcer, Uveitis, Glaucoma 2.Inflammatory conditions like Acute Conjunctivitis etc 3.Patients with severe systemic illness 4.Pregnant women

Design outcomes

Secondary

Measure	Time frame
Any adverse event reported voluntarily,observed or enquired. Recurrence in sign and symptoms of Shushkakshipaka(DES)Timepoint: 1 months 15days	—

Primary

Measure	Time frame
To evaluate the efficacy of Mahoushadha Anjana with Triphala Ghrita in the management of Shushkakshipaka(DES)Timepoint: 1 months 15days	—

Countries

India

Contacts

Public ContactDr Raj Kumar Sharma

National Institute of Ayurveda

vaidya.rajsoni@gmail.com7017970757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026